MARATTO

article · Diagnostics

Machine Learning for Enhanced COPD Diagnosis: A Comparative Analysis of Classification Algorithms

20241 citationOpen accessSuez Canal University

Abstract

<b>Background</b>: In the United States, chronic obstructive pulmonary disease (COPD) is a significant cause of mortality. As far as we know, it is a chronic, inflammatory lung condition that cuts off airflow to the lungs. Many symptoms have been reported for such a disease: breathing problems, coughing, wheezing, and mucus production. Patients with COPD might be at risk, since they are more susceptible to heart disease and lung cancer. <b>Methods</b>: This study reviews COPD diagnosis utilizing various machine learning (ML) classifiers, such as Logistic Regression (LR), Gradient Boosting Classifier (GBC), Support Vector Machine (SVM), Gaussian Naïve Bayes (GNB), Random Forest Classifier (RFC), K-Nearest Neighbors Classifier (KNC), Decision Tree (DT), and Artificial Neural Network (ANN). These models were applied to a dataset comprising 1603 patients after being referred for a pulmonary function test. <b>Results</b>: The RFC has achieved superior accuracy, reaching up to 82.06% in training and 70.47% in testing. Furthermore, it achieved a maximum F score in training and testing with an ROC value of 0.0.82. <b>Conclusions</b>: The results obtained with the utilized ML models align with previous work in the field, with accuracies ranging from 67.81% to 82.06% in training and from 66.73% to 71.46% in testing.

Research topics

  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Artificial Intelligence in Healthcare
  • Phonocardiography and Auscultation Techniques

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.3390/diagnostics14242822

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.